Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

This publication has 17 references indexed in Scilit:

• Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.
  The Journal of Experimental Medicine, 1990
• Anti-inflammatory drugs and Alzheimer disease
  The Lancet, 1990
• The CD59 antigen is a structural homologue of murine Ly‐6 antigens but lacks interferon inducibility
  European Journal of Immunology, 1990
• CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
  The Journal of Experimental Medicine, 1989
• 20 KDa homologous restriction factor of complement resembles T cell activating protein
  Biochemical and Biophysical Research Communications, 1989
• Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
  Journal of Clinical Investigation, 1989
• Complement activation in amyloid plaques in Alzheimer’s dementia
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1988
• Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
  Neurobiology of Aging, 1988
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
  Biochemistry, 1979
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970